Form D · Commercial

PCR Investment Fund V, LLC

Houston, TX · CIK 0001972386

Offering snapshot reported Apr 26, 2024 · SEC filing

Reported sold
Yet to sell
Offering amount: $150M
Investors reported
0
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 26, 2024AmendmentYet to sellNo comparison0SEC filing
Apr 26, 2024Amendment$28,875,000$28,375,000vs Apr 6, 2023180SEC filing
Apr 6, 2023Initial$500,000No comparison3SEC filing
Apr 6, 2023InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$3M (estimated)
Finders' fees
$0
Form D file number
021-478117
The placement agent will receive a fee that is equal to up to 2.0% of the amounts sold.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
N/ANonePCR Finance Group, LLC · CRD 315067

Source: Form D, filed Apr 26, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Pcr Investment Company, Llc Director, Executive

Issuer details

Industry: Commercial (See others in industry)

Address:
1360 Post Oak Blvd. Suite 1900
Houston, TX, 77056